The Intergroup study employed bolus 5-fluorouracil (5-FU) and leucovorin delivered before, during and after radiation. This regimen was chosen because it represented the standard of care at the ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.

We assessed the effectiveness of cetuximab plus chronomodulated irinotecan, 5-fluorouracil (5-FU), leucovorin ... in 93% and 36% of patients before and after dose reduction.

We have now investigated its efficacy and toxicity in patients who have progressed during or after docetaxel chemotherapy. Results: Patients had a median age of 70 years (range 48-77), median baseline ...

Each patient had two patches microneedled with a dermapen before having one patch treated with an application of 5-fluorouracil and the other patch treated with tacrolimus. Patients had treatment ...

Patients were assessed before randomization ... Group Given Fluorouracil, Leucovorin, and Oxaliplatin. Twelve patients — six in each group (0.5 percent) — died within 1 month after the ...

To assess the efficacy of 5-fluorouracil in treating actinic keratoses ... respectively, were evaluated. After 4 weeks of treatment, total clearance and mean lesion count reduction were 52.6 ...

ORLANDO — Topical 5-fluorouracil and calcipotriene proved ... a characteristic that Ruiz states did not impact the endpoints. After a follow-up time of 15 months, results showed that 92% of ...

Since the 1950s, a chemotherapy drug known as 5-fluorouracil has been used to treat many types of cancer, including blood ...

The rates of death from toxic effects were 2.3% in the TPF group and 5.5% in the PF group. As compared with the standard regimen of cisplatin and fluorouracil ... before radiotherapy and 3 months ...